Andrew Cooper
Stock Analyst at Raymond James
(3.12)
# 1,191
Out of 4,713 analysts
121
Total ratings
44.86%
Success rate
0.35%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Upgrades: Strong Buy | $120 | $78.40 | +53.06% | 7 | Nov 8, 2024 | |
| RVTY Revvity | Maintains: Outperform | $144 → $146 | $112.00 | +30.36% | 5 | Nov 5, 2024 | |
| HOLX Hologic | Maintains: Outperform | $93 → $95 | $71.74 | +32.42% | 10 | Nov 5, 2024 | |
| DHR Danaher | Maintains: Outperform | $310 → $300 | $229.81 | +30.54% | 6 | Oct 23, 2024 | |
| EXAS Exact Sciences | Reiterates: Market Perform | n/a | $56.93 | - | 8 | Sep 26, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $650 → $660 | $522.57 | +26.30% | 5 | Jul 25, 2024 | |
| CDNA CareDx | Downgrades: Market Perform | n/a | $21.52 | - | 16 | May 13, 2024 | |
| NTRA Natera | Downgrades: Outperform | $68 → $85 | $160.60 | -47.07% | 5 | Feb 20, 2024 | |
| QDEL QuidelOrtho | Downgrades: Outperform | $100 → $76 | $45.04 | +68.74% | 12 | Feb 14, 2024 | |
| AVTR Avantor | Maintains: Outperform | $23 → $26 | $21.20 | +22.64% | 12 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $27 | $31.77 | -15.01% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $6.57 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $50.04 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.49 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $27 | $13.50 | +100.00% | 3 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $40.44 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $45 | $18.42 | +144.30% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.54 | - | 5 | Sep 22, 2021 |
Haemonetics
Nov 8, 2024
Upgrades: Strong Buy
Price Target: $120
Current: $78.40
Upside: +53.06%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $144 → $146
Current: $112.00
Upside: +30.36%
Hologic
Nov 5, 2024
Maintains: Outperform
Price Target: $93 → $95
Current: $71.74
Upside: +32.42%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $310 → $300
Current: $229.81
Upside: +30.54%
Exact Sciences
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $56.93
Upside: -
Thermo Fisher
Jul 25, 2024
Maintains: Outperform
Price Target: $650 → $660
Current: $522.57
Upside: +26.30%
CareDx
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.52
Upside: -
Natera
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $160.60
Upside: -47.07%
QuidelOrtho
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $45.04
Upside: +68.74%
Avantor
Jan 26, 2024
Maintains: Outperform
Price Target: $23 → $26
Current: $21.20
Upside: +22.64%
Nov 13, 2023
Upgrades: Outperform
Price Target: $27
Current: $31.77
Upside: -15.01%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $6.57
Upside: -
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $50.04
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.49
Upside: -
Mar 3, 2023
Maintains: Outperform
Price Target: $25 → $27
Current: $13.50
Upside: +100.00%
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $40.44
Upside: -
Nov 18, 2022
Initiates: Outperform
Price Target: $45
Current: $18.42
Upside: +144.30%
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.54
Upside: -